As vaccine rollout looms, so do big questions around supply chains

Healthcare IT News: As Pfizer and Moderna wait for the U.S. Federal and Drug Administration to issue an emergency use authorization for their respective vaccines, the importance of a seamless – or at least well-connected – supply chain has become increasingly clear.

According to the U.S. Department of Health and Human Services, the first rollout of the vaccine is likely to be very limited, with state governors and public health departments directing allocation of the first available doses.

Read article